LEVENT KESKINTEPE
Pilots at Barchetta Dr, Las Vegas, NV
License number
Nevada A5072986
Issued Date
Jul 2015
Expiration Date
Jul 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
2213 Barchetta Dr, Las Vegas, NV 89134
Professional information
Executive Laboratory Director At Sirm
Position:
Executive Laboratory Director at SIRM
Location:
Las Vegas, Nevada Area
Industry:
Medical Practice
Work:
SIRM
-
Executive Laboratory Director
Education:
The University of Georgia 1989 - 1994
Executive Laboratory Director At Imc
Position:
Executive Laboratory Director at SIRM
Location:
Las Vegas, Nevada Area
Industry:
Medical Practice
Work:
SIRM
since 2001
-
Executive Laboratory Director
Education:
The University of Georgia 2000 - 2006
PhD, Reproductive Physiology
PhD, Reproductive Physiology
Method Of Oocyte Cryopreservation Including Piercing The Zona Pellucida Prior To Vitrification
US Patent:
2008005, Feb 28, 2008
Filed:
Jul 19, 2007
Appl. No.:
11/826998
Inventors:
Geoffery Sher - Las Vegas NV, US
Levent Keskintepe - Las Vegas NV, US
Levent Keskintepe - Las Vegas NV, US
International Classification:
C12N 5/06
US Classification:
435374000
Abstract:
The present invention relates to the cryopreservation and preparation of warmed oocytes for fertilization. Cryopreservation of oocytes using vitrification methods is disclosed. Exemplary techniques include making a vent in the zona pellucida surrounding the oocyte; contacting the oocyte with a vitrification solution comprising at least one cryoprotectant; and vitrifying the oocyte. Further methods of warming the vitrified oocyte, in preparation for intracellular sperm injection are disclosed, allowing for the assessment of successful fertilization.
Methods Of Determining Human Egg Competency
US Patent:
2009016, Jun 25, 2009
Filed:
Dec 2, 2008
Appl. No.:
12/326329
Inventors:
Geoffrey Sher - Las Vegas NV, US
Levent Keskintepe - Las Vegas NV, US
Levent Keskintepe - Las Vegas NV, US
Assignee:
INOVA MANAGEMENT COMPANY - Las Vegas NV
International Classification:
A61B 17/435, C12Q 1/68
US Classification:
600 34, 435 6
Abstract:
The inventors have discovered inter alia, that when the chromosome complement of a first polar body (PB-I) is normal, it alone is in more than 80% of cases sufficient to predict that an embryo which has developed from an oocyte associated with the PB-I is also normal and competent. As such, the invention relates to methods of identifying competent oocytes and embryos suitable for use during in vitro fertilization.
Methods Of Determining Human Egg Competency
US Patent:
2006014, Jun 29, 2006
Filed:
Nov 17, 2005
Appl. No.:
11/280855
Inventors:
Geoffrey Sher - Las Vegas NV, US
Levent Keskintepe - Las Vegas NV, US
Levent Keskintepe - Las Vegas NV, US
International Classification:
C12Q 1/68, C12N 15/00
US Classification:
435006000, 800021000
Abstract:
The inventors have discovered inter alia, that when the chromosome complement of a first polar body (PB-I) is normal, it alone is in more than 80% of cases sufficient to predict that an embryo which has developed from an oocyte associated with the PB-I is also normal and competent. As such, the invention relates to methods of identifying competent oocytes and embryos suitable for use during in vitro fertilization.
Methods Of Developing A Stem Cell Line
US Patent:
2006016, Jul 20, 2006
Filed:
Nov 17, 2005
Appl. No.:
11/280865
Inventors:
Geoffrey Sher - Las Vegas NV, US
Levent Keskintepe - Las Vegas NV, US
Levent Keskintepe - Las Vegas NV, US
International Classification:
C12N 5/08
US Classification:
435366000
Abstract:
The invention relates to a methodology for creating an embryonic stem cell line. The stem cells derived from the invention are of substantially better quality of human stem cells currently known to exist. The inventors have discovered inter alia, that when the chromosome complement of a first polar body (PB-I) is normal, it alone is in more than 80% of cases sufficient to predict that an embryo which has developed from an oocyte associated with the PB-I is also euploid and competent. Euploid embryos ensure are a key prerequisite in the making of euploid embryonic stem cells. This allows the technician minimize the number of disrupted embryos by only disrupting those embryos determined to be euploid.